Chambers, SA; DeSousa, JM; Huseman, ED; Townsend, SD. The DARK side of total synthesis: Strategies and tactics in psychoactive drug production ACS Chem. Neurosci., 17 Oct 2018, 9 (10), 2307–2330. 8.1 MB. https://doi.org/10.1021/acschemneuro.7b00528 #8
Ellis, CR; Kruhlak, NL; Kim, MT; Hawkins, EG; Stavitskaya, L. Predicting opioid receptor binding affinity of pharmacologically unclassified designer substances using molecular docking PLOS ONE, 24 May 2018, 13 (5), e0197734. 5.5 MB. https://doi.org/10.1371/journal.pone.0197734 #Oxycodone
Devereaux, AL; Mercer, SL; Cunningham, CW. DARK classics in chemical neuroscience: Morphine ACS Chem. Neurosci., 17 Oct 2018, 9 (10), 2395-2407. 3.0 MB. https://doi.org/10.1021/acschemneuro.8b00150 #6
Shulgin, AT. Oxycontin, oxycodone, heroin Ask Dr. Shulgin Online, Center for Cognitive Liberty & Ethics, 20 Feb 2003.
N-(2-Hydroxybenzyl)-N-methyl-β-hydroxy-4-carboxyamphetamine · β-HO-4-HOOC-MA-NBOH
3,4-DMPEA-NBMD · N-(2,3-Methylenedioxybenzyl)-3,4-dimethoxyphenethylamine
25H-NBMD · N-(2,3-Methylenedioxybenzyl)-2,5-dimethoxyphenethylamine
2C-2-NBOMe · 2C-MMDA-2-NBOMe
β-Hydroxymescaline NB imine
Codeine N-oxide · Genocodeine